Please assess the completion status of the following clinical trial:

Trial Title: Escitalopram (Lexapro®) In Patients With Major Depression With Atypical Features

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. age 18 to 65 years,~2. DSM-IV episode of Major Depression non-psychotic with atypical features.~3. ≥19 score on the 29-item HAM-D,~4. ability to give informed consent, if patients are of child-bearing potential~5. A minimum 2-week washout from existing psychotropics (5 weeks for fluoxetine).~Exclusion Criteria:~1. bipolar depression,~2. Any Axis I psychotic disorder~3. currently suicidal or suicide risk,~4. history of substance abuse in the previous 12 months,~5. history of hypersensitivity to escitalopram, or citalopram~6. serious or unstable medical disorders,~7. starting or terminating psychotherapy during the previous 12 weeks,~8. ECT treatment in the previous 3 months,~9. pregnancy or planning pregnancy.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- A (Type: EXPERIMENTAL): Lexapro

Based on this trial design, predict the completion outcome and termination type (if applicable).